Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the target of a large decrease in short interest in July. As of July 15th, there was short interest totaling 6,244 shares, a decrease of 65.7% from the June 30th total of 18,178 shares. Based on an average daily volume of 25,674 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.4% of the company’s stock are short sold.
Analyst Ratings Changes
AKAN has been the subject of several research analyst reports. Weiss Ratings cut shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, May 18th. Wall Street Zen upgraded shares of Akanda from a “strong sell” rating to a “sell” rating in a report on Saturday. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Get Our Latest Stock Analysis on Akanda
Akanda Stock Down 22.6%
Akanda (NASDAQ:AKAN – Get Free Report) last posted its quarterly earnings data on Tuesday, June 9th. The company reported ($317.90) EPS for the quarter.
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Read More
- Five stocks we like better than Akanda
- Appleās Earnings Setup Puts Its Record Rally and AI Patience to the Test
- Oil Prices Are Surging and These 4 Stocks Are Cashing In
- Innovative ETF Strategies That Are Paying Off This Summer
- Forget Tesla: These 2 Earnings Reports Reveal Where the Auto Market Is Heading
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
